Further investigations have demonstrated that curcumin inhibits both the COX and LOX metabolic pathways by downregulating the levels of phospholipase A2, phospholipase Cγ1, and PGE2 in colonic mucosa and tumor tissues, significantly suppressing tumor invasion and disease progression [75]. The gene discussed is LOX; the disease is neoplasm.